SEC Comment Letter for ELITE PHARMACEUTICALS (ELTP) — Apr 22, 2009
ELITE PHARMACEUTICALS INC /NV/ (ELTP) (CIK 0001053369)
Date: April 22, 2009 · CIK: 0001053369 · Accession: 0000000000-09-021057
AI Filing Summary & Sentiment
Reasoning
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 April 17, 2009 Mark I. Gittelman Chief Financial Officer and Treasurer Elite Pharmaceuticals, Inc. 165 Ludlow Avenue Northvale, NJ 07647 Re: Elite Pharmaceuticals, Inc. Item 4.01 Form 8-K filed February 19, 2009 Item 4.01 Form 8-K/A filed March 12, 2009 Item 4.01 Form 8-K/A filed April 14, 2009 File No. 1-15697
Dear Mr. Gittelman:
We have completed our review of your Form 8-K and related filings and have no further comments at this time. S i n c e r e l y , S a s h a P a r i k h S t a f f A c c o u n t a n t
Show Raw Text
Via Facsimile and U.S. Mail Mail Stop 6010 April 17, 2009 Mark I. Gittelman Chief Financial Officer and Treasurer Elite Pharmaceuticals, Inc. 165 Ludlow Avenue Northvale, NJ 07647 Re: Elite Pharmaceuticals, Inc. Item 4.01 Form 8-K filed February 19, 2009 Item 4.01 Form 8-K/A filed March 12, 2009 Item 4.01 Form 8-K/A filed April 14, 2009 File No. 1-15697 Dear Mr. Gittelman: We have completed our review of your Form 8-K and related filings and have no further comments at this time. S i n c e r e l y , S a s h a P a r i k h S t a f f A c c o u n t a n t